Venus Remedies has received a marketing authorisation (MA) from regulatory authorities in Myanmar for its antibiotic adjuvant entity, Elores. The company plans to launch the product in Myanmar by April.
Venus has already received patents for Elores from 46 countries. In November 2013 it also received an MA for the product from Guatemala. Venus added that registration procedures for the drug in 13 EU member states and 15 other countries, including South Korea, South Africa and Saudi Arabia, were in advanced stages. Elores was initially launched in India in January 2013.